Pre-transplant Liver Disorders: Post-transplant Impact on Developing Venocclusive Disease/Sinusoidal Obstruction Syndrome and Other Hepatic Problems

  • Howard M. ShulmanEmail author


The identification of pre-transplant liver disorders is important to avoid post-transplant development of venocclusive disease/sinusoidal obstruction syndrome (VOD/SOS) or hepatic decompensation. The pre-transplant disorders which predispose an increased risk of death are inflammatory conditions like viral hepatitis, fibrosing liver disorders such as cirrhosis or nonalcoholic steatohepatitis (NASH), myeloproliferative disorders, and prior history of liver toxicity after exposure to certain oncology drugs. Recognition of these disorders will affect the eligibility for transplant or may lead to a change in the pre-transplant conditioning regimen. The pathophysiology of VOD/SOS is presented. The clinical and histologic gold standards for diagnosing VOD/SOS are discussed, since occluded venules may be clinically silent.


Venocclusive disease (VOD) Sinusoidal occlusive syndrome (SOS) Risk factors for VOD/SOS Pre-transplant liver disorders Hepatic iron overload pre-hematopoietic stem cell transplant Transvenous liver biopsy Pathophysiology of mylotarg hepatotoxicity Pathophysiology of VOD/SOS 


  1. 1.
    Hogan WJ, Maris M, Storer B, et al. Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. Blood. 2004;103(1):78–84.CrossRefGoogle Scholar
  2. 2.
    Angelucci E, Muretto P, Lucarelli G, et al. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood. 1997;90(3):994–8.Google Scholar
  3. 3.
    Strasser SI, Kowdley KV, Sale GE, McDonald GB. Iron overload in bone marrow transplant recipients. Bone Marrow Transplant. 1998;22(2):167–73.CrossRefGoogle Scholar
  4. 4.
    McDonald GB, Frieze D. A problem-oriented approach to liver disease in oncology patients. Gut. 2008;57(7):987–1003.CrossRefGoogle Scholar
  5. 5.
    DeLeve LD, Valla DC, Garcia-Tsao G. American Association for the Study Liver D. Vascular disorders of the liver. Hepatology. 2009;49(5):1729–64.CrossRefGoogle Scholar
  6. 6.
    Mohty M, Malard F, Abecassis M, et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015;50(6):781–9.CrossRefGoogle Scholar
  7. 7.
    DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis. 2002;22(1):27–42.CrossRefGoogle Scholar
  8. 8.
    Rajvanshi P. Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy. Blood. 2002;99(7):2310–4.CrossRefGoogle Scholar
  9. 9.
    McDonald GB, Freston JW, Boyer JL, DeLeve LD. Liver complications following treatment of hematologic malignancy with anti-CD22 calicheamicin (Inotuzumab Ozogamicin). Hepatology. 2018. In press.Google Scholar
  10. 10.
    Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology. 1994;19(5):1171–81.CrossRefGoogle Scholar
  11. 11.
    Shulman HM, McDonald GB, Matthews D, et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology. 1980;79(6):1178–91.Google Scholar
  12. 12.
    McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4(1):116–22.CrossRefGoogle Scholar
  13. 13.
    Ma C, Brunt EM. Terminal hepatic venule injury in liver biopsies of allogeneic haematopoietic stem cell recipients-a study of 63 cases. Histopathology. 2016;68(7):996–1003.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Clinical Research DivisionFred Hutchinson Cancer Research CenterSeattleUSA
  2. 2.Department of PathologyUniversity of Washington School of MedicineSeattleUSA
  3. 3.Pathology SectionSeattle Cancer Care AllianceSeattleUSA

Personalised recommendations